Ireland
--:--IST
Latest
Clinical Trials in Sweden / NCT06922487
Recruiting Observational

Assessment of Tiredness During Awake Resection of Intracerebral Tumors

NCT06922487 · tracked via the Priya Life Science Sweden tracker
Phase
Observational
Started
2024-11-11
Last updated
2025-04-10

Condition(s) studied

Brain Tumor AdultAwake Surgery

Investigational drug(s) / intervention(s)

Karolinska Sleepiness Scale, KSS

Karolinska Sleepiness Scale, KSS: Assessment of sleepiness during resection using KSS

Study summary

Occasional patients with intracranial tumors need to have a planned awakening during surgery to avoid major disability from the tumor resection. During the awake part of the surgery an increasing degree of tiredness is observed. For the surgeon to plan the resection knowledge of the degree and speed of tiredness/sleepiness evolution is important.

The goal of this single center study is to use the "Karolinska Sleepiness Scale" during and after awake surgery for neurosurgical tumor resection to quantify the time available for surgical intervention.

Participants are adults having planned surgery for open resection of intracranial tumor with a planned awakening for assessment during surgery. Participants will be asked to grade postoperative sleepiness using the "Karolinska Sleepiness Scale".

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult (\>18 years old) * Elective supra or infratentorial tumor resection via craniotomy * Surgical need for awake surgery * Cognitive function allowing informed consent. Exclusion Criteria: * Tumor resection without awake surgery * Morbid obesitas

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Intensive and Perioperative Care, Skane University Hospital Lund Sweden Recruiting

More Region Skane trials in Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06922487 on ClinicalTrials.gov ↗ ← All trials in Sweden